- Nov 25, 2025 Foghorn Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
- Nov 05, 2025 Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
- Nov 03, 2025 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
- Oct 30, 2025 Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
- Oct 16, 2025 Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
- Aug 27, 2025 Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
- Aug 05, 2025 Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
- May 22, 2025 Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences
- May 14, 2025 Foghorn Therapeutics Provides First Quarter 2025 Financial and Corporate Update
- May 05, 2025 Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
Displaying 1 - 10 of 17